All data are based on the daily closing price as of October 9, 2024

Seegene Introduces New PCR Assay to Combat Mpox Variant Spread in Africa

The company launches an advanced RUO test to detect high-risk mpox Clade I and support global containment efforts
South Korea
s 096530.KQ Mid and Small Cap 2000
Share this on

South Korea’s Seegene Inc. has unveiled its latest research-use-only (RUO) PCR assay to address the rising threat of the mpox virus variant, Clade Ib, which is spreading in Africa. The Novaplex™ MPXV/OPXV plus Assay is designed to detect non-variola Orthopoxvirus and mpox virus (MPXV), with a specific focus on the more transmissible and lethal Clade I.

This new assay aligns with the World Health Organization’s (WHO) target product profiles, ensuring it meets key criteria for distinguishing between mpox variants Clade I and II. Seegene has responded rapidly to the global mpox outbreak, which was declared a public health emergency by the WHO in August 2024.

In addition to the new assay, Seegene has developed other diagnostic tools, including tests that simultaneously detect mpox alongside other viral infections like herpes and varicella-zoster. These efforts reflect the company’s commitment to supporting countries affected by the mpox outbreak, which has spread beyond Africa to regions like Sweden and Pakistan, according to the Africa Centres for Disease Control and Prevention.

Seegene’s innovative approach continues to enhance global research capabilities in the fight against mpox, particularly in regions facing rising case numbers and significant mortality rates.

 

Share this on
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top